Highlights from MSK Digital Health Pipeline
Highlights from MSK Life Sciences Pipeline
Overview
The Office of Entrepreneurship and Commercialization (OEC) manages a world-class portfolio of entrepreneurship opportunities, intellectual property, and other technology advances across an extensive range of life sciences, digital health, and related healthcare portfolios. OEC is led by Yashodhara Dash, MBBS, PhD, MBA, who serves as MSK’s Vice President of Entrepreneurship & Commercialization.
OEC’s mission is to ensure that MSK innovation is developed and applied for the common good. We pursue this mission in partnership with MSK’s institution-wide community of innovators—while building productive relationships with companies, investors, and academic-research institutions throughout the global healthcare sector.
OEC is staffed an expert team of technology development professionals. They bring rigorous scientific, healthcare, and business backgrounds to the challenges of developing, managing, protecting, and commercializing MSK innovation; facilitating startup creation; partnering with industry; interacting with regulators; and much more.
Key Programs and Initiatives
OEC works with industry partners to translate research breakthroughs into real-world products and services with transformative potential for cancer patients around the world. In a continuously evolving environment defined by global healthcare needs, regulatory shifts, economic challenges, and other variables, OEC is open for business.
Learn more about our key programs and initiatives, including:
- Life Sciences Business Development and Licensing
- Digital Heath Business Development and Licensing
- MSK Therapeutics Accelerator
- MSK Innovation Hub (iHub)
- MSK Entrepreneurship Initiative (EI)
- MSK Therapeutics Bridge Labs (TxBL)
- Technology Development Investment Fund (TDIF)
- Innovation Events and News
- OEC Operations & Finance
Partnering opportunities across a broad array of new technologies and ready-to-use products in MSK’s life sciences, digital health, and related healthcare portfolios
Nurturing and encouraging a culture of entrepreneurship and innovation across MSK to spur startup creation and investment opportunities for our valued industry partners.
Commercialization programs and accelerators which connect industry partners to MSK expertise and resources in order to empower cutting-edge projects with oncology-focused goals.
Our Staff
OEC is staffed an expert team of technology development professionals. They bring rigorous scientific, healthcare, and business backgrounds to the challenges of developing, managing, protecting, and commercializing MSK innovation; facilitating startup creation; partnering with industry; interacting with regulators; and much more.
Yashodhara Dash, MBBS, PhD, MBA
Yashodhara Dash is MSK’s Vice President in the Office of Entrepreneurship and Commercialization (OEC). In October 2024, she was appointed to lead the Office (then known as the Office of Technology Development), where her team includes business development and product development professionals, as well as an Operations and Finance unit.
Under Yashodhara’s leadership, OEC actively supports the entire lifecycle of drug development at MSK, starting from discoveries made in the lab to the point at which startups are formed or technologies are licensed to pharma/biotech. The Office’s impact can be measured in many ways, including with Fast Company’s 2025 recognition of MSK as one of the “Best Workplaces for Innovators,” and MSK’s longstanding record as one of the top academic-research institutions in terms of licensing revenue.
Yashodhara’s responsibilities include leading an interrelated network of innovation-focused programs and initiatives, which are designed to drive entrepreneurship, industry partnerships, and commercialization—while empowering MSK’s community of innovators. These include the MSK Innovation Hub and iHub Challenge program; the MSK Therapeutics Accelerator and Cohort program; the Entrepreneurship Initiative (EI); the Technology Development Investment Fund (TDIF and related funds); and MSK Therapeutics Bridge Labs (Tx Bridge Labs); along with Life Sciences & Digital Health business development and licensing teams.
Yashodhara joined MSK in 2007 and has previously held a series of management roles in this Office. She received her PhD degree in immunology from the University of Connecticut Health Center in 2007. She also holds an MBA degree from the University of Connecticut and an MBBS degree from India’s SCB Medical College. She has taught an undergraduate seminar about drug development and the biotechnology industry, “The Economics and Science of Medicine,” at Yale University for the past eight years.
Office of Entrepreneurship and Commercialization
Memorial Sloan Kettering Cancer Center
1275 York Avenue
New York, NY 10065
Courier Address for FedEx, UPS, and DHL
At this time, the Office of Entrepreneurship and Commercialization is not accepting Courier deliveries.